Charles Explorer logo
🇬🇧

Pramipexole and pergolide in the treatment of depression in Parkinson?s disease: a national multicentre prospective randomized study

Publication at First Faculty of Medicine, Faculty of Medicine in Pilsen |
2003

Abstract

An 8-month multicentre prospective randomized study comparing dopamine receptor agonists pramipexole and pergolide as add-L-dopa therapy on depression in non-demented patients suffering from both mild and moderate depression and PD.